ConjuChem, LLC is a privately biotechnology company with a corporate office located in Los Angeles, California. ConjuChem is owned by NantWorks, LLC. ConjuChem creates novel, next-generation medicines using unique, long-acting therapeutic peptides. Underlying all ConjuChem compounds are bioconjugation platforms called Drug Affinity Complex (DACâ„¢) and Preformed Conjugate-Drug Affinity Complex (PC-DACâ„¢). When applied to a given peptide, DACâ„¢ and PC- DACâ„¢ can create new drugs with similar therapeutic activities but with significantly longer durations of activity and improved safety profiles.
| Website | http://www.conjuchem.com |
| Revenue | $6 million |
| Employees | 10 (2 on RocketReach) |
| Founded | 1997 |
| Phone | +1 424-208-7025 |
| Industry | Biotechnology, Pharmaceuticals, Biotechnology Research, Healthcare, Science and Engineering, Drug Manufacturing & Research |
| Keywords | Biotechnology, Therapeutic Peptides, Drug Development, Clinical Development, Pharmaceutical Research, Drug Discovery, Peptide Therapeutics, Preclinical Development, Biotechnology Research, Pharmaceutical Development, Novel Medicines, Peptide Drugs, Pharmaceutical, Biotech, Therapeutics, Medicine |
| Competitors | Novartis, Merck AH, AstraZeneca, Genentech, Amgen, Regeneron, Biogen, Lilly India, Ablynx, PeptiDream Inc. +39 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies |
Looking for a particular ConjuChem employee's phone or email?
ConjuChem Questions
The ConjuChem annual revenue was $6 million in 2026.
Tom Ulich is the Exec VP R and D of ConjuChem.
2 people are employed at ConjuChem.
The NAICS codes for ConjuChem are [541, 54171, 54, 5417, 541714].
The SIC codes for ConjuChem are [87, 873].
Top ConjuChem Employees
-
Tom Ulich
Exec VP R and D at ConjuChem
New York, NY, US12 -
艳玲 白
Human Resources Director at ConjuChem
Beijing, China1
Related Companies
